Your browser doesn't support javascript.
loading
Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis.
Styrkarsdottir, Unnur; Helgason, Hannes; Sigurdsson, Asgeir; Norddahl, Gudmundur L; Agustsdottir, Arna B; Reynard, Louise N; Villalvilla, Amanda; Halldorsson, Gisli H; Jonasdottir, Aslaug; Magnusdottir, Audur; Oddson, Asmundur; Sulem, Gerald; Zink, Florian; Sveinbjornsson, Gardar; Helgason, Agnar; Johannsdottir, Hrefna S; Helgadottir, Anna; Stefansson, Hreinn; Gretarsdottir, Solveig; Rafnar, Thorunn; Almdahl, Ina S; Brækhus, Anne; Fladby, Tormod; Selbæk, Geir; Hosseinpanah, Farhad; Azizi, Fereidoun; Koh, Jung Min; Tang, Nelson L S; Daneshpour, Maryam S; Mayordomo, Jose I; Welt, Corrine; Braund, Peter S; Samani, Nilesh J; Kiemeney, Lambertus A; Lohmander, L Stefan; Christiansen, Claus; Andreassen, Ole A; Magnusson, Olafur; Masson, Gisli; Kong, Augustine; Jonsdottir, Ingileif; Gudbjartsson, Daniel; Sulem, Patrick; Jonsson, Helgi; Loughlin, John; Ingvarsson, Thorvaldur; Thorsteinsdottir, Unnur; Stefansson, Kari.
Afiliação
  • Styrkarsdottir U; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Helgason H; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Sigurdsson A; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
  • Norddahl GL; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Agustsdottir AB; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Reynard LN; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Villalvilla A; Institute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, UK.
  • Halldorsson GH; Institute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, UK.
  • Jonasdottir A; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Magnusdottir A; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Oddson A; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Sulem G; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Zink F; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Sveinbjornsson G; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Helgason A; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Johannsdottir HS; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Helgadottir A; Department of Anthropology, University of Iceland, Reykjavik, Iceland.
  • Stefansson H; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Gretarsdottir S; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Rafnar T; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Almdahl IS; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Brækhus A; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Fladby T; Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
  • Selbæk G; Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.
  • Hosseinpanah F; Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway.
  • Azizi F; Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
  • Koh JM; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Tang NLS; Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.
  • Daneshpour MS; Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Mayordomo JI; Centre for Old Age Psychiatry Research, Innlandet Hospital Trust, Ottestad, Norway.
  • Welt C; Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Braund PS; Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Samani NJ; Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Kiemeney LA; Department of Chemical Pathology and Laboratory for Genetics of Disease Susceptibility, Li Ka Shing Institute of Health Sciences, and School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Lohmander LS; Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Christiansen C; Division of Medical Oncology, Lozano Blesa University Hospital, Zaragoza, Spain.
  • Andreassen OA; Division of Endocrinology, Metabolism and Diabetes, University of Utah, Salt Lake City, Utah, USA.
  • Magnusson O; NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, UK.
  • Masson G; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
  • Kong A; NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, UK.
  • Jonsdottir I; Radboud University Medical Center, Radboud Institute for Health Science, Nijmegen, the Netherlands.
  • Gudbjartsson D; Orthopaedics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Sulem P; Nordic Bioscience, Herlev, Denmark.
  • Jonsson H; NORMENT, KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Ingvarsson T; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Thorsteinsdottir U; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  • Stefansson K; deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Nat Genet ; 49(5): 801-805, 2017 May.
Article em En | MEDLINE | ID: mdl-28319091
ABSTRACT
We performed a genome-wide association study of total hip replacements, based on variants identified through whole-genome sequencing, which included 4,657 Icelandic patients and 207,514 population controls. We discovered two rare signals that strongly associate with osteoarthritis total hip replacement a missense variant, c.1141G>C (p.Asp369His), in the COMP gene (allelic frequency = 0.026%, P = 4.0 × 10-12, odds ratio (OR) = 16.7) and a frameshift mutation, rs532464664 (p.Val330Glyfs*106), in the CHADL gene that associates through a recessive mode of inheritance (homozygote frequency = 0.15%, P = 4.5 × 10-18, OR = 7.71). On average, c.1141G>C heterozygotes and individuals homozygous for rs532464664 had their hip replacement operation 13.5 years and 4.9 years earlier than others (P = 0.0020 and P = 0.0026), respectively. We show that the full-length CHADL transcript is expressed in cartilage. Furthermore, the premature stop codon introduced by the CHADL frameshift mutation results in nonsense-mediated decay of the mutant transcripts.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoartrite do Quadril / Genoma Humano / Proteínas da Matriz Extracelular / Análise de Sequência de DNA / Predisposição Genética para Doença / Proteína de Matriz Oligomérica de Cartilagem Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoartrite do Quadril / Genoma Humano / Proteínas da Matriz Extracelular / Análise de Sequência de DNA / Predisposição Genética para Doença / Proteína de Matriz Oligomérica de Cartilagem Idioma: En Ano de publicação: 2017 Tipo de documento: Article